Harbour Investments’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.9K Sell
1,376
-3
-0.2% -$68 ﹤0.01% 2609
2026
Q1
$29.5K Buy
1,379
+66
+5% +$1.37K ﹤0.01% 2647
2025
Q4
$28.1K Hold
1,313
– – ﹤0.01% 2260
2025
Q3
$22K Buy
+1,313
New +$19.7K ﹤0.01% 2287
2021
Q4
– Sell
-328
Closed -$9K – 3262
2021
Q3
$9K Buy
328
+12
+4% +$366 ﹤0.01% 2728
2021
Q2
$10K Buy
+316
New +$9.33K ﹤0.01% 2735

Other funds holding MD

Harbour Investments's MD Position: Q2 2026 in Review

Harbour Investments reduced its Pediatrix Medical (MD) stake by 0.22% in Q2 2026, selling an estimated $68 and leaving 1,376 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

Harbour Investments first reported a position in MD in Q2 2021 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Harbour Investments held 1,376 shares of Pediatrix Medical worth $34.9K as of Q2 2026.
  • Harbour Investments sold 3 Pediatrix Medical shares in Q2 2026, an estimated $68.
  • Pediatrix Medical made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2609 holding.
  • Harbour Investments first reported a position in Pediatrix Medical in Q2 2021 and has held it in 6 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.